Loading...
Guest User
Welcome! Please login.
| IPO Listing At | BSE SME |
| SME IPO Issue Type | Book Build Issue |
| Total Issue Size | ₹24.77 Cr |
| Reserved for Market Maker | ₹1.24 Cr |
| Net Issue Size | ₹24.77 Cr |
| Fresh Issue | ₹23.53 Cr |
| Face Value | ₹10 Per Equity Share |
| Price Band | ₹122.00-129.00 per share |
| BSE Code | 544694 |
| Registrar | Kfin Technologies Ltd. |
| Lead Managers | Sobhagya Capital Options Pvt.Ltd. |
Disclaimer: GMP is sourced from grey market dealers and is indicative only. Always conduct your own due diligence.
* Allotment, Refund, Demat Credit & Listing dates are tentative and subject to change.
Minimum bid: 2,000 shares · Multiples of 1,000 shares
Accretion Nutraveda is a manufacturer of Ayurvedic and nutraceutical formulations, offering a wide range of dosage forms such as tablets, capsules, syrups, powders, oils, and topical products, including balms, creams, and gels.
The company functions as a Contract Development and Manufacturing Organization (CDMO), catering to both Indian and overseas clients. Its international footprint spans markets like Sri Lanka, Singapore, and the United States. By blending traditional Ayurvedic knowledge with contemporary nutraceutical research, Accretion Nutraveda develops products targeting key wellness areas such as liver health, women’s care, bone and joint support, brain health, and respiratory well-being.
Business Verticals:
Direct Exports: Contributed around 38% of revenue, reflecting steady and ongoing growth.
The company operates a manufacturing unit in Gujarat with a built-up area of nearly 10,763 square feet. The facility is fitted with advanced infrastructure, including 13 air handling units, dedicated processing zones, and robust quality assurance systems. It holds multiple certifications such as GMP, WHO-GMP, FSSC 22000, ISO 9001:2015, ISO 45001:2018, and Halal, and is also licensed by FSSAI, underscoring its strong compliance and quality standards.
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Purchase of Machineries for Automation in existing Manufacturing unit | 4.22 |
| 2 | Purchase of Machineries for New Manufacturing Setup | 8.03 |
| 3 | Funding working capital requirements of the Company | 5.50 |
| 4 | General Corporate Purposes | 3.69 |
| 5 | Issue Expenses | 3.33 |
| Total | 24.77 |
| Period Ended | 30 Sep 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 16.35 | 10.86 | 4.64 | 4.06 |
| Total Income | 14.07 | 16.06 | 5.20 | 3.07 |
| Profit After Tax | 2.33 | 2.61 | 0.82 | 0.28 |
| EBITDA | 3.29 | 3.65 | 1.21 | 0.59 |
| NET Worth | 8.26 | 5.35 | 1.08 | 0.26 |
| Reserves and Surplus | 2.95 | 4.86 | 0.72 | -0.10 |
| Total Borrowing | 4.43 | 3.86 | 2.17 | 1.97 |
| Amount in ₹ Crore | ||||
| KPI | Sep 30, 2025 | Mar 31, 2025 |
|---|---|---|
| ROE | 68.54% | 81.22% |
| ROCE | 49.09% | 36.98% |
| Debt / Equity | 0.54% | 0.72% |
| RoNW | 56.50% | 48.85% |
| PAT Margin | 16.59% | 16.33% |
| EBITDA Margin | 23.36% | 22.79% |
| Price to Book Value | 7.71 | 8.76 |
| Metric | Pre IPO | Post IPO |
|---|---|---|
| EPS (₹) | 4.91 | 6.44 |
| P/E (x) | 26.27 | 20.02 |
| Promoter Holding | 100% | 73.48% |
| Market Cap | ₹93.40 Cr. | |
